Ingredient
Triacetyl Retinoyl Phytosphingosine
Triacetyl Retinoyl Phytosphingosine is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is known teratogen and fetal development.
- Retinol Complex
- Modified Retinoid
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Triacetyl Retinoyl Phytosphingosine and pregnancy
Not Recommended
- Known teratogen
- Fetal development
Triacetyl retinoyl phytosphingosine is a modified retinoid combining retinoic acid with other molecules. Like all retinoid derivatives, it has structural similarity to vitamin A compounds that are known to affect fetal development. According to ACOG, systemic retinoids are known teratogens that can cause serious birth defects. While topical absorption is generally lower than oral forms, ACOG recommends avoiding all retinoid derivatives during pregnancy as a precautionary measure. The specific safety data for this modified retinoid during pregnancy has not been established, but its retinoid structure raises the same theoretical concerns as other vitamin A derivatives. Most obstetricians and dermatologists advise pregnant women to avoid all retinoid compounds, including newer derivatives like this one, until more safety data is available. The FDA has not specifically evaluated this ingredient for pregnancy safety, and the absence of data combined with its chemical structure warrants caution.
Triacetyl Retinoyl Phytosphingosine and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
This ingredient is a fat-soluble retinoid derivative that could potentially accumulate in fatty tissues and breast milk. Vitamin A and its derivatives can transfer into breast milk, and excessive vitamin A intake by infants can lead to toxicity. The AAD notes that most dermatologists recommend postponing retinoid use until after weaning due to theoretical risks of infant exposure through breast milk. While specific data on this modified retinoid is lacking, its lipophilic nature and structural similarity to vitamin A compounds raise similar concerns. Given the lack of safety data specific to breastfeeding and the known transfer of vitamin A compounds to breast milk, conservative medical advice is to avoid retinoid derivatives while breastfeeding. Safer alternatives are available for anti-aging benefits during this period.
Triacetyl Retinoyl Phytosphingosine and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, this retinoid derivative can be beneficial for addressing skin texture changes and signs of aging that may have developed during pregnancy. The combination with phytosphingosine may provide additional skin barrier support. Start with lower frequency use as postpartum skin may be more sensitive. This ingredient can help with hyperpigmentation, fine lines, and skin renewal that many women seek to address after pregnancy. Monitor for irritation and use sunscreen diligently as retinoids increase photosensitivity.
Triacetyl Retinoyl Phytosphingosine and trying to conceive
Not Recommended
- Known teratogen
- Builds up in tissue
Women trying to conceive should discontinue retinoid derivatives including this ingredient. Because it's fat-soluble, it can accumulate in tissues and remain in the body even after stopping use. Most doctors recommend discontinuing retinoids at least one month before attempting conception. While topical retinoids have lower systemic absorption than oral forms, the precautionary principle applies when actively trying to conceive. Once you begin trying, it's safest to avoid all retinoid derivatives to ensure no fetal exposure if conception occurs.
Triacetyl Retinoyl Phytosphingosine and PCOS
Safe to Use
Retinoid derivatives like this can be particularly beneficial for PCOS-related acne. They help regulate cell turnover, reduce clogged pores, and improve skin texture. The phytosphingosine component adds anti-inflammatory benefits that may further help with acne. This ingredient does not interact with hormones or affect androgen levels in PCOS. It works through skin cell regulation mechanisms that are independent of hormonal pathways. For women with PCOS experiencing hormonal acne, retinoid derivatives are often a key component of dermatological treatment. This modified form may offer benefits with potentially less irritation than traditional retinol.
Triacetyl Retinoyl Phytosphingosine and general use
Safe to Use
- Irritant
- Increases sun sensitivity
Triacetyl retinoyl phytosphingosine is a newer retinoid derivative designed to provide anti-aging benefits with potentially less irritation than traditional retinol. The phytosphingosine component may help support the skin barrier during retinoid use. Like all retinoids, this ingredient can cause irritation, redness, and increased sun sensitivity, particularly when first starting use or with higher concentrations. Users should introduce it gradually and always use broad-spectrum sunscreen during the day. While specific long-term safety data for this modified retinoid is limited compared to traditional retinol, it appears to work through similar mechanisms for anti-aging benefits. For non-pregnant, non-breastfeeding adults, it can be used safely with appropriate precautions for sun protection and monitoring for irritation.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Triacetyl Retinoyl Phytosphingosine, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store